Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2008 Oct-Nov;17(7):552-7.
doi: 10.1097/IJG.0b013e31816299d4.

High prevalence of anxiety and depression in patients with primary open-angle glaucoma

Fumihiko Mabuchi  1 , Kimio Yoshimura, Kenji Kashiwagi, Kunihiko Shioe, Zentaro Yamagata, Shigenobu Kanba, Hiroyuki Iijima, Shigeo Tsukahara
Affiliations
Multicenter Study

High prevalence of anxiety and depression in patients with primary open-angle glaucoma

Fumihiko Mabuchi et al. J Glaucoma. 2008 Oct-Nov.

Abstract

Purpose: To assess anxiety and depression in patients with primary open-angle glaucoma (POAG).

Design: Multicenter prospective case-control study.

Participants: Two hundred thirty patients with POAG and 230 sex-matched and age-matched reference subjects with no chronic ocular conditions except cataracts.

Intervention: Anxiety and depression were evaluated using Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of 2 subscales with ranges of 0 to 21, representing anxiety (HADS-A) and depression (HADS-D).

Main outcome measure: The prevalence of POAG patients with anxiety (a score of more than 10 on the HADS-A) or depression (a score of more than 10 on the HADS-D) was compared with that in the reference subjects. The prevalence of patients with depression was compared between the POAG patients with and without current beta-blocker eye drops.

Results: The prevalence (13.0%) of POAG patients with anxiety was significantly higher (P=0.030) than in the reference subjects (7.0%). The prevalence (10.9%) of POAG patients with depression was significantly higher (P=0.026) than in the reference subjects (5.2%). Between the POAG patients with and without beta-blocker eye-drops, no significant difference (P=0.93) in the prevalence of depression was noted.

Conclusions: POAG was related to anxiety and depression. No significant relationship between the use of beta-blocker eye-drops and depression was noted.

PubMed Disclaimer

Publication types

Substances